Sign up
Quantellect · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
RepublicanHouse

K. Michael Conaway bought AbbVie Inc (NYSE: ABBV)

K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 2 trades in AbbVie Inc (ABBV) since 2015, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: K. Michael Conaway bought $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on June 8, 2015. Since that trade, ABBV is up +508.39% against the S&P 500 up +320.64%, an outperformance of +187.75%.

Across these filings, K. Michael Conaway has been a balanced trader of ABBV (a buy-to-sell ratio of 1.00). The most recent disclosed ABBV transaction shown was dated September 12, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2015–2016

K. Michael Conaway's ABBV trades vs the price

ABBV is up +508.39% since K. Michael Conaway bought on June 8, 2015, versus +320.64% for the S&P 500.

Performance since this trade

Price change since trade
+508.39%
S&P 500 change since trade
+320.64%
Outperformance vs S&P 500
+187.75%

All K. Michael Conaway ABBV trades

TradedTypeSizeReturnEst. profit
September 12, 2016SELL$42.81+515.07%
June 8, 2015BUY$43.28+508.39%+$23K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

K. Michael Conaway & ABBV trading FAQ

Is it legal for K. Michael Conaway to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did K. Michael Conaway buy ABBV?

K. Michael Conaway disclosed a purchase of $1,001 - $15,000 of AbbVie Inc (ABBV) on June 8, 2015, according to public STOCK Act filings.

How has ABBV performed since K. Michael Conaway's trade?

Since K. Michael Conaway bought ABBV on June 8, 2015, the stock is up +508.39%, versus +320.64% for the S&P 500 over the same period, an outperformance of +187.75%.

How many times has K. Michael Conaway traded ABBV?

K. Michael Conaway has disclosed 2 ABBV trades since 2015 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

K. Michael Conaway's ABBV tradesAll congressional filings for AbbVie IncK. Michael Conaway's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.